Cardinal Health (CAH) CEO Deborah Weitzman Sells 7,354 Shares

What Happened
Deborah Weitzman, CEO of Cardinal Health's PSS segment, sold a total of 7,354 shares in open-market transactions on August 18, 2026. The sales were reported as three disposals: 6,665 shares at a weighted-average price of $235.30 ($1,568,275), 408 shares at $236.59 ($96,529), and 281 shares at $237.44 ($66,721), for aggregate proceeds of approximately $1,731,525. These were sales (code "S") — routine insider sell transactions rather than purchases.

Key Details

• Transaction date: August 18, 2026 (filed on August 20, 2026). Filing appears timely (within the typical 2-business-day Form 4 window).
• Shares sold and reported values:
  • 6,665 shares @ weighted avg $235.30 = $1,568,275 (F1)
  • 408 shares @ weighted avg $236.59 = $96,529 (F2)
  • 281 shares @ weighted avg $237.44 = $66,721 (F3)
  • Total sold: 7,354 shares for approx. $1,731,525.
• Footnotes: prices are weighted averages; sales occurred in multiple trades at ranges:
  • F1: $235.17–$236.02
  • F2: $236.24–$237.143
  • F3: $237.2615–$237.6285
    The filing states the reporting person can provide per-trade price details on request.
• Shares owned after transaction: not specified in the summary data provided here — see the full Form 4 for post-transaction holdings.
• No 10b5-1 plan, tax-withholding, or gift notation was provided in the supplied details.

Context
Open-market sales by executives can be routine (diversification, liquidity, tax planning) and do not by themselves indicate a change in company outlook. Purchases generally carry more direct signal of insider confidence. For complete context and exact post-sale holdings, consult the full Form 4 filing (accession 0001942639-26-000003).